Nevertheless, it is essential to underline that the heterogeneity of results in literature may depend on different study methods or bias in selection of patients as well; hence, further studies are needed to confirm the lack of correlation between [18F]FDOPA uptake and the IDH status of gliomas. This evidence concerns the gene IDH1 and central nervous system cancer.